Quick and Selective
- the examination of the urine sample will last no longer than 10 min;
- selective towards bladder cancer – our preliminary data suggest, that the bladder cancer test specificity is as high as 80-90%;
Low-Cost and Easy-to-Use
- one test will cost less than 4 EUR;
- easy to use – the device is composed of small spectrometer and exchangeable test-tube which works as urine container at the same time. Thank to that it is comfortable to use even at home by nonprofessionals;
Digital
The results can be read, managed, and archived on mobile devices and computers which gives completely new opportunities for staying healthy.
MEET UroSCAN
OUR STORY
Urine is one of the easiest biological materials for diagnostic. It has less complicated structure than blood, and it’s easier to characterize. The sample collection is easy and non-invasive manner. The samples have a high volume, so that their analysis gives the possibility to measure several parameters at once. They are characterized by high pepties and proteins stability in specimen and the obtained results reflect the physiological state of the body. Read moreOUR VISION
The UroScan’s strategy will be leading provider of fast and reliable diagnostic tests for various diseases basing on urine examination. There is increasing number of scientific reports suggesting the presence of various biomarkers in the urine. Although, there is still lack of methods which could be used widely in healthcare.TECHNOLOGY
UroScan company is a biotechnological start-up which is designed for conducting R&D and implementation of new solutions in the diagnostic area. The aim of the company is to develop tools which will make diagnostic easier, faster and more affordable. UroScan company will introduce the portable devices for general urine examination and non-invasive method t for bladder cancer detection but in further perspective the company will launch dedicated tests for chronic kidney disease and ovarian cancer. In the long term the Company will provide research and development in the detection of various types of cancer in urine. Team
Katarzyna Pala
Co-Founder & CEO
Krzysztof Urbański
Co-Founder & CTO
Dawid Nidzworski
Co-Founder
Tomasz Gondek
Co-Founder
Contact
UroSCAN Sp. z o.o.
District Court for Wrocław Fabryczna in Wrocław
VI Commercial Department of the National Court Register
KRS: 0000701185
NIP: 8943117228
REGON: 368596016
Share capital: 5 000 zł
ul. Bierutowska 57-59, 51-317 Wrocław (Wrocławski Park Biznesu 3)
Katarzyna Pala